Biohaven Pharmaceutical Holding Company Ltd

(NYSE:BHVN)

Latest On Biohaven Pharmaceutical Holding Company Ltd (BHVN):

Date/Time Type Description Signal Details
2023-05-12 21:12 ESTNewsBiohaven Non-GAAP EPS of -$0.98N/A
2023-03-24 07:34 ESTNewsBiohaven Non-GAAP EPS of -$1.27 beats by $0.01N/A
2023-03-22 08:38 ESTNewsBiohaven acquires rights to potential brain disorder drug BHV-8000 for $10M upfrontN/A
2023-03-10 05:36 ESTNewsBiohaven: Spun And Done - Time To ExitN/A
2023-02-21 22:11 ESTNewsBiohaven's spinal muscular atrophy therapy gets FDA fast track statusN/A
2023-01-04 17:02 ESTNewsBiohaven initiated at overweight at JP Morgan on neurological targetsN/A
2022-12-08 04:49 ESTNewsBiohaven Ltd: Assessing The SpinoffN/A
2022-11-09 21:19 ESTNewsBiohaven Non-GAAP EPS of -$1.25N/A
2022-10-21 04:41 ESTNewsBiohaven prices upsized 25M of stock offering at $10.50/shareN/A
2022-10-18 16:23 ESTNewsBiohaven stock falls 5% after the bell on 20M share offeringN/A
2022-10-07 13:52 ESTNewsBiotech in recovery; but Piper Sandler cites negative fund flowsN/A
2022-10-07 13:49 ESTNewsM&A may be a tailwind for biotech sector into end of year, analyst saysN/A
2022-10-07 13:40 ESTNews'New' Biohaven up 81% days after Pfizer acquisition as investors see pipeline potentialN/A
2022-10-06 23:49 ESTNewsBiohaven Stub May Provide An Interesting Setup For InvestorsN/A
2022-09-29 23:19 ESTNewsBiohaven says ALS candidate failed in key trialN/A
2022-09-28 00:37 ESTNewsPfizer acquisition of Biohaven Pharmaceuticals expected to close Oct. 3N/A
2022-09-19 19:50 ESTNewsBiohaven announces timeline for spinoffN/A
2022-08-17 15:12 ESTNewsBiohaven: Non-Standard Merger Consideration Makes This A BuyN/A
2022-08-16 05:06 ESTNewsSoros Fund Management takes new stakes in GCP, Biohaven, TeslaN/A
2022-08-05 15:33 ESTNewsBiohaven Pharmaceuticals Non-GAAP EPS of -$3.82 misses by $1.57, revenue of $194M misses by $16.6MN/A
2022-07-07 09:59 ESTNewsBiohaven begins enrolling in late-stage trial of spinal muscular atrophy therapyN/A
2022-06-15 23:08 ESTNewsBiohaven Deal: Pfizer Gives Away A FreerollN/A
2022-06-01 11:56 ESTNewsFederal Trade Commission to hold pharma merger and antitrust workshopN/A
2022-05-23 14:53 ESTNewsBiohaven phase 3 trial in genetic muscle disorder fails to reach significance overall due to low disease progressionN/A
2022-05-23 14:53 ESTNewsBiohaven gets FDA review for nasal spray zavegepant to treat migraineN/A
2022-05-11 01:00 ESTNewsBiohaven Pharmaceuticals Non-GAAP EPS of -$1.62 beats by $0.65, revenue of $318.85M beats by $135.14MN/A
2022-05-11 01:00 ESTNewsPfizer to acquire Biohaven in ~$11.6B deal; Biohaven stock soars 72%N/A
2022-05-06 21:00 ESTNewsBiohaven Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-04-27 19:21 ESTNewsPfizer, Biohaven's Vydura gets approval in EU to prevent/treat migraineN/A
2022-04-14 05:28 ESTNewsBiohaven Pharmaceutical: Recent Growth Will ContinueN/A
2022-02-26 00:18 ESTNewsBiohaven Pharmaceuticals Non-GAAP EPS of -$2.32 misses by $0.39, revenue of $190.01M beats by $14.47MN/A
2022-02-26 00:18 ESTNewsBiohaven in licensing pact with Bristol Myers; to acquire Channel BiosciencesN/A
2022-02-26 00:18 ESTNewsPfizer, Biohaven's rimegepant gets EMA panel nod for migraine treatmentN/A
2022-02-26 00:18 ESTNewsBiohaven Pharmaceutical Holding Company Ltd. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-26 00:17 ESTNewsBiohaven Pharmaceutical Holding's (BHVN) CEO Vlad Coric on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-25 05:15 ESTNewsBiohaven Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-22 19:32 ESTNewsBiohaven begins enrollment in phase 2/3 trial of Nurtec ODT in chronic rhinosinusitisN/A
2022-02-15 01:21 ESTNewsPfizer/ Biohaven announce late-stage migraine trial met main goals in Asia PacificN/A
2022-02-01 23:30 ESTNewsNew thematic psychedelic ETF hits the marketN/A
2022-01-28 21:24 ESTNewsAurinia Pharmaceuticals quick uptick on renewed takeover speculation on Biogen newsN/A
2022-01-18 18:11 ESTNewsBiohaven’s Troriluzole to undergo glioblastoma trial designed to study multiple therapiesN/A
2022-01-14 05:01 ESTNewsAurinia Pharmaceuticals reverses decline after report on potential M&A interestN/A
2022-01-10 16:33 ESTNewsBiohaven forms research collaboration to advance TRPM3 antagonists for pain managementN/A
2022-01-06 09:41 ESTNewsBiohaven reports preliminary Q4 Nurtec ODT revenue of $190MN/A
2021-12-07 06:52 ESTNewsBiohaven names Vlad Coric as Chairman, appoints new CFON/A
2021-12-06 12:13 ESTNewsBiohaven says pivotal study for intranasal migraine therapy met main goalsN/A
2021-12-06 12:13 ESTNewsBiohaven names new CEO, CFON/A
2021-11-18 11:13 ESTNewsBiohaven, Artizan to work on Parkinson's drug discovery programN/A
2021-11-17 13:22 ESTNewsBiohaven's migraine med Nurtec approved in KuwaitN/A
2021-11-10 03:44 ESTNewsPfizer to gain ex-U.S. rights to Biohaven migraine med Nurtec in up to $1.24B dealN/A

About Biohaven Pharmaceutical Holding Company Ltd (BHVN):

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological diseases and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as id developing Rimegepant for preventive treatment of migraine and other non-migraine indications; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole, which is in phase III clinical trials for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 that is in phase I clinical trial for neuropsychiatric indications; and Verdiperstat, a product that is in phase III trial for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.

See Advanced Chart

General

  • Name Biohaven Pharmaceutical Holding Company Ltd
  • Symbol BHVN
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 825
  • Fiscal Year EndDecember
  • IPO Date2017-05-04
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.biohavenpharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 71.25
  • Price/Book (Most Recent Quarter) 31.82
  • Enterprise Value Revenue 73.75
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$10.49
  • Next Year EPS Estimate -$5.57
  • Next Quarter EPS Estimate -$2.73
  • Operating Margin -1014%
  • Return on Assets -78%
  • Revenue 63.63 million
  • Earnings Per Share -$9.14
  • Revenue Per Share $1.08
  • Gross Profit 45.93 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 4.42 billion
  • EBITDA -356321504
  • Analyst Target Price $102.09
  • Book Value Per Share $2.09
View More

Share Statistics

  • Shares Outstanding 61.93 million
  • Shares Float 54.37 million
  • % Held by Insiders 1379%
  • % Held by Institutions 117.55%
  • Shares Short 5.76 million
  • Shares Short Prior Month 5.98 million
  • Short Ratio 11.39
  • Short % of Float 13%
  • Short % of Shares Outstanding 9%
View More

Technicals

  • Beta 1.08
  • 52 Week High $100.77
  • 52 Week Low $28.26
  • 50 Day Moving Average 82.8
  • 200 Day Moving Average 80.62
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$2.69-$2.56-4.98%
2020-09-302020-11-09$17.66 million-$2.67-$2.866.58%
2020-06-302020-08-10$9.7 million-$2.55-$2.8410.27%
2020-03-312020-05-07$1.15 million-$2.39-$2.462.94%
2019-12-312020-02-25$N/A-$2.85-$1.91-49.31%
2019-09-302019-11-01$N/A-$2.04-$1.57-30.24%
2019-06-302019-08-08$N/A-$4.67-$2.09-123.21%
2019-03-312019-05-07$N/A-$1.41-$1.505.94%
2018-12-312019-02-28$N/A-$1.33-$1.21-10.12%
2018-09-302018-11-14$N/A-$1.53-$1.08-42.33%
2018-06-302018-08-14$N/A-$1.01-$1.053.68%
2018-03-312018-05-15$N/A-$2.32-$1.17-98.29%
2017-12-312018-03-06$N/A-$0.75-$1.3544.34%
2017-09-302017-11-14$N/A-$1.19-$1.243.78%
2017-06-302017-08-14$N/A-$1.78-$0.62-185.94%
2017-03-312017-06-16$N/A-$1.74-$1.45-20%

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Chart:

Biohaven Pharmaceutical Holding Company Ltd (BHVN) News:

Below you will find a list of latest news for Biohaven Pharmaceutical Holding Company Ltd (BHVN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-1717.50CALL0 0274.95TRUE00
2025-04-17200CALL0 0155.86TRUE00
2025-04-1722.50CALL0 0144.19TRUE00
2025-04-17255.5CALL0 693.92TRUE00
2025-04-17301.4CALL93 3025103.9FALSE-0.85-0.38
2025-04-17350.65CALL3 353105.12FALSE-0.3-0.32
2025-04-17400.05CALL0 472110.99FALSE00
2025-04-1742.50.4CALL0 129131.19FALSE00
2025-04-17450.15CALL13 1835120.41FALSE0.150
2025-04-1747.51.35CALL0 386209.28FALSE00
2025-04-17500.15CALL0 111221.44FALSE00
2025-04-1752.50.05CALL0 123232.74FALSE00
2025-04-17550.1CALL0 92147.55FALSE00
2025-04-1757.50.8CALL0 109253.21FALSE00
2025-04-17600.71CALL0 259255.92FALSE00
2025-04-1762.53.6CALL0 20271.35FALSE00
2025-04-17650.2CALL0 27278.03FALSE00
2025-04-17701.75CALL0 137293.48FALSE00
2025-04-17751.55CALL0 6307.55FALSE00
2025-04-17803.6CALL0 11320.46FALSE00
2025-04-1717.50PUT0 0221.47FALSE00
2025-04-17200.45PUT0 10142.27FALSE00
2025-04-1722.50.5PUT1 1896.18FALSE0.50
2025-04-17251.25PUT1 32298.82FALSE0.350.39
2025-04-17304.5PUT36 213123.51TRUE1.740.63
2025-04-17356.5PUT0 233116.79TRUE00
2025-04-17409.95PUT0 159158.93TRUE00
2025-04-1742.511.2PUT0 0144.95TRUE00
2025-04-174515.76PUT0 15134.74TRUE00
2025-04-1747.58.3PUT0 7181.92TRUE00
2025-04-175015.55PUT0 15172.62TRUE00
2025-04-1752.517.5PUT0 0177.82TRUE00
2025-04-175510.5PUT0 17181.69TRUE00
2025-04-1757.512.5PUT0 8190.56TRUE00
2025-04-176026.5PUT0 0192.43TRUE00
2025-04-1762.518PUT0 0206.94TRUE00
2025-04-176517.1PUT0 0214.54TRUE00
2025-04-17700PUT0 0221.74TRUE00
2025-04-17750PUT0 0234.6TRUE00
2025-04-17800PUT0 0253.84TRUE00
2025-05-16150CALL0 0154.89TRUE00
2025-05-1617.50CALL0 0143.81TRUE00
2025-05-16200CALL0 071.04TRUE00
2025-05-1622.50CALL0 085.34TRUE00
2025-05-16250CALL0 0101.86TRUE00
2025-05-1627.50CALL0 081.86TRUE00
2025-05-16303.6CALL0 4291FALSE00
2025-05-1632.51.86CALL1 10293.03FALSE1.860
2025-05-16351.95CALL0 12292.18FALSE00
2025-05-1637.52CALL0 1376.12FALSE00
2025-05-16400CALL0 083.13FALSE00
2025-05-1642.51CALL0 484.79FALSE00
2025-05-16150PUT0 0175.15FALSE00
2025-05-1617.50PUT0 0136.3FALSE00
2025-05-16200.88PUT5 0102.06FALSE0.880
2025-05-1622.50PUT0 098.27FALSE00
2025-05-16252.43PUT5 196.69FALSE0.350.17
2025-05-1627.53.23PUT0 295.75FALSE00
2025-05-16305.6PUT22 500106.73TRUE5.60
2025-05-1632.50PUT0 0117.69TRUE00
2025-05-16357.58PUT0 1794.02TRUE00
2025-05-1637.50PUT0 0102.84TRUE00
2025-05-16400PUT0 0111.32TRUE00
2025-05-1642.50PUT0 0101.56TRUE00
2025-07-18150CALL0 0122.05TRUE00
2025-07-1817.50CALL0 066.37TRUE00
2025-07-182019CALL0 1571.38TRUE00
2025-07-1822.515.63CALL0 069.42TRUE00
2025-07-18250CALL0 076.23TRUE00
2025-07-1827.55.6CALL0 475.89TRUE00
2025-07-18304.09CALL1 680.2FALSE4.090
2025-07-1832.53.5CALL0 677.72FALSE00
2025-07-18352.4CALL3 109175.78FALSE-0.63-0.21
2025-07-1837.53.1CALL0 2374.49FALSE00
2025-07-18402CALL0 26663.52FALSE00
2025-07-1842.53CALL0 5871.73FALSE00
2025-07-18450.75CALL10 131071.16FALSE0.750
2025-07-1847.51.45CALL0 2867.8FALSE00
2025-07-18500.83CALL0 7471.44FALSE00
2025-07-1852.51.05CALL0 678.39FALSE00
2025-07-18551.97CALL0 35104.04FALSE00
2025-07-1857.52.25CALL0 3106.98FALSE00
2025-07-18601.4CALL0 6110.26FALSE00
2025-07-18650.45CALL0 253116.8FALSE00
2025-07-18700.75CALL0 102122.59FALSE00
2025-07-18151.2PUT0 0104.2FALSE00
2025-07-1817.50.68PUT0 8100.97FALSE00
2025-07-18201PUT0 178.44FALSE00
2025-07-1822.50PUT0 092.9FALSE00
2025-07-18253PUT0 4675.43FALSE00
2025-07-1827.54.41PUT10 2777.41FALSE0.510.13
2025-07-18305.78PUT0 11978.69TRUE00
2025-07-1832.54.3PUT0 2478.79TRUE00
2025-07-18358.9PUT0 3880.58TRUE00
2025-07-1837.56PUT0 9881.17TRUE00
2025-07-184011.73PUT0 2575.64TRUE00
2025-07-1842.510.2PUT0 1082.78TRUE00
2025-07-18459PUT0 22095.74TRUE00
2025-07-1847.511.2PUT0 184.28TRUE00
2025-07-18500PUT0 088.25TRUE00
2025-07-1852.50PUT0 091.77TRUE00
2025-07-18550PUT0 0100.79TRUE00
2025-07-1857.50PUT0 094.12TRUE00
2025-07-18600PUT0 091.87TRUE00
2025-07-18650PUT0 099.25TRUE00
2025-07-18700PUT0 0112.67TRUE00
2025-10-17150CALL0 051.25TRUE00
2025-10-1717.50CALL0 068.17TRUE00
2025-10-17200CALL0 071.7TRUE00
2025-10-1722.50CALL0 076.84TRUE00
2025-10-17258.64CALL0 1275.36TRUE00
2025-10-1727.58.7CALL0 1277.04TRUE00
2025-10-17305.1CALL2 1175.44FALSE5.10
2025-10-1732.50CALL0 077.17FALSE00
2025-10-17354.7CALL0 277.49FALSE00
2025-10-1737.50CALL0 074.41FALSE00
2025-10-17403.6CALL0 671.97FALSE00
2025-10-1742.53CALL0 10272.39FALSE00
2025-10-17453.11CALL0 3669.72FALSE00
2025-10-1747.51.75CALL0 462.61FALSE00
2025-10-17500CALL0 069.06FALSE00
2025-10-17550CALL0 063.59FALSE00
2025-10-17150PUT0 089.9FALSE00
2025-10-1717.50PUT0 072.98FALSE00
2025-10-17202PUT0 579.38FALSE00
2025-10-1722.51.75PUT0 4276.36FALSE00
2025-10-17252.85PUT0 282.78FALSE00
2025-10-1727.50PUT0 075.47FALSE00
2025-10-17307.4PUT1 177.49TRUE7.40
2025-10-1732.58.9PUT0 378.98TRUE00
2025-10-17350PUT0 079.05TRUE00
2025-10-1737.58.7PUT0 382.88TRUE00
2025-10-174012.8PUT0 683.25TRUE00
2025-10-1742.50PUT0 079.31TRUE00
2025-10-174517.23PUT0 577.61TRUE00
2025-10-1747.50PUT0 080.16TRUE00
2025-10-17500PUT0 083.05TRUE00
2025-10-17550PUT0 074.22TRUE00
2025-12-19150CALL0 064.53TRUE00
2025-12-1917.523.2CALL0 5176.85TRUE00
2025-12-192020.5CALL0 4066.77TRUE00
2025-12-1922.519CALL0 467.25TRUE00
2025-12-192516.5CALL0 268.4TRUE00
2025-12-19306.9CALL0 16073.2FALSE00
2025-12-19356.36CALL0 16563.49FALSE00
2025-12-19404.5CALL0 20461.1FALSE00
2025-12-1942.53.18CALL0 100270.77FALSE00
2025-12-19454.13CALL0 15469.63FALSE00
2025-12-1947.50CALL0 070.53FALSE00
2025-12-19503CALL0 40362.06FALSE00
2025-12-1952.50CALL0 057.59FALSE00
2025-12-19555.5CALL0 1966.63FALSE00
2025-12-1957.50CALL0 057.62FALSE00
2025-12-19600.87CALL1 2964.47FALSE0.870
2025-12-1962.50CALL0 061.68FALSE00
2025-12-19652.42CALL0 962.62FALSE00
2025-12-19700.5CALL0 171.63FALSE00
2025-12-19750CALL0 083.51FALSE00
2025-12-19800CALL0 085.68FALSE00
2025-12-19150.76PUT0 267.42FALSE00
2025-12-1917.51.3PUT0 4261.71FALSE00
2025-12-19204.34PUT0 182.03FALSE00
2025-12-1922.53PUT0 8577.25FALSE00
2025-12-19254.1PUT0 12172.03FALSE00
2025-12-19304.6PUT0 1374.28TRUE00
2025-12-193511.5PUT1 11075.82TRUE11.50
2025-12-194010.47PUT0 3074.38TRUE00
2025-12-1942.510.01PUT0 171.13TRUE00
2025-12-194519.5PUT1 176.54TRUE19.50
2025-12-1947.512.09PUT0 172.13TRUE00
2025-12-195018.8PUT0 1076.17TRUE00
2025-12-1952.50PUT0 081.27TRUE00
2025-12-19550PUT0 069.43TRUE00
2025-12-1957.50PUT0 061.74TRUE00
2025-12-19600PUT0 075.6TRUE00
2025-12-1962.50PUT0 073.08TRUE00
2025-12-19650PUT0 082.16TRUE00
2025-12-19700PUT0 079.41TRUE00
2025-12-19750PUT0 084.02TRUE00
2025-12-19800PUT0 088.32TRUE00
2026-01-16150CALL0 074.55TRUE00
2026-01-1617.50CALL0 063.98TRUE00
2026-01-162012.4CALL0 2074.17TRUE00
2026-01-1622.50CALL0 071.21TRUE00
2026-01-162510.4CALL0 14773.92TRUE00
2026-01-16307.7CALL0 11671.88FALSE00
2026-01-16356.2CALL0 32569.98FALSE00
2026-01-1637.55.97CALL0 171.93FALSE00
2026-01-16403.54CALL2 17767.85FALSE3.540
2026-01-1642.56.9CALL0 1168.94FALSE00
2026-01-16453.2CALL0 18968.23FALSE00
2026-01-1647.50CALL0 068.89FALSE00
2026-01-16502.9CALL0 19666.34FALSE00
2026-01-1652.56.6CALL0 160.39FALSE00
2026-01-16552CALL0 765.7FALSE00
2026-01-1657.50CALL0 056.59FALSE00
2026-01-16600CALL0 064.67FALSE00
2026-01-16650CALL0 058.81FALSE00
2026-01-16150PUT0 065.69FALSE00
2026-01-1617.50PUT0 079.34FALSE00
2026-01-16200PUT0 068.81FALSE00
2026-01-1622.53.7PUT0 377.03FALSE00
2026-01-16250PUT0 078.77FALSE00
2026-01-16304.1PUT0 171.66TRUE00
2026-01-16357.3PUT0 865.55TRUE00
2026-01-1637.59.25PUT0 2070.95TRUE00
2026-01-164010PUT0 271.43TRUE00
2026-01-1642.50PUT0 068.38TRUE00
2026-01-16450PUT0 071.84TRUE00
2026-01-1647.50PUT0 070.72TRUE00
2026-01-16500PUT0 068.76TRUE00
2026-01-1652.50PUT0 068.7TRUE00
2026-01-16550PUT0 062.24TRUE00
2026-01-1657.50PUT0 068.29TRUE00
2026-01-16600PUT0 077.31TRUE00
2026-01-16650PUT0 075.56TRUE00
2026-12-18150CALL0 068.1TRUE00
2026-12-1817.50CALL0 057.56TRUE00
2026-12-18200CALL0 066.07TRUE00
2026-12-1822.50CALL0 064.88TRUE00
2026-12-18250CALL0 064.99TRUE00
2026-12-18309.5CALL0 361.38FALSE00
2026-12-183511.4CALL0 157.98FALSE00
2026-12-1837.56.35CALL0 456.63FALSE00
2026-12-184012.5CALL0 158.31FALSE00
2026-12-1842.50CALL0 062.7FALSE00
2026-12-184514.75CALL0 3054.4FALSE00
2026-12-1847.55CALL0 259.1FALSE00
2026-12-18500CALL0 060.92FALSE00
2026-12-1852.50CALL0 056.69FALSE00
2026-12-18550CALL0 054.02FALSE00
2026-12-1857.50CALL0 055.98FALSE00
2026-12-18605.15CALL0 160.59FALSE00
2026-12-18650CALL0 059.55FALSE00
2026-12-18150PUT0 064.9FALSE00
2026-12-1817.50PUT0 057.99FALSE00
2026-12-18200PUT0 065.67FALSE00
2026-12-1822.54.5PUT0 2267.98FALSE00
2026-12-18255.9PUT0 265.95FALSE00
2026-12-18300PUT0 068.03TRUE00
2026-12-183510.8PUT0 562.36TRUE00
2026-12-1837.50PUT0 062.91TRUE00
2026-12-184010.25PUT0 3065.1TRUE00
2026-12-1842.50PUT0 065.07TRUE00
2026-12-18450PUT0 063.97TRUE00
2026-12-1847.50PUT0 065.46TRUE00
2026-12-18500PUT0 062.74TRUE00
2026-12-1852.50PUT0 063.56TRUE00
2026-12-18550PUT0 064.59TRUE00
2026-12-1857.50PUT0 065.82TRUE00
2026-12-18600PUT0 060.67TRUE00
2026-12-18650PUT0 066.98TRUE00
2027-01-15150CALL0 061.21TRUE00
2027-01-1517.50CALL0 059.54TRUE00
2027-01-152014.7CALL0 069.88TRUE00
2027-01-1522.513.4CALL0 161.86TRUE00
2027-01-152512.5CALL0 662.93TRUE00
2027-01-153020.25CALL0 357.3FALSE00
2027-01-15359.61CALL0 259.97FALSE00
2027-01-1537.512.7CALL0 063.39FALSE00
2027-01-15407.27CALL0 10061.61FALSE00
2027-01-1542.514.35CALL0 4064.56FALSE00
2027-01-15450CALL0 064.5FALSE00
2027-01-1547.50CALL0 064.52FALSE00
2027-01-15500CALL0 063.6FALSE00
2027-01-1552.50CALL0 057.49FALSE00
2027-01-15558.75CALL0 060.33FALSE00
2027-01-1557.59CALL0 153.27FALSE00
2027-01-15607.85CALL0 356.44FALSE00
2027-01-15657.7CALL0 1059.15FALSE00
2027-01-15150PUT0 062.98FALSE00
2027-01-1517.50PUT0 067.06FALSE00
2027-01-15203.4PUT0 265.97FALSE00
2027-01-1522.53.7PUT0 263.67FALSE00
2027-01-15250PUT0 069.31FALSE00
2027-01-15308.43PUT0 164.31TRUE00
2027-01-153512.5PUT0 264.86TRUE00
2027-01-1537.510.64PUT0 1064.36TRUE00
2027-01-154012.41PUT0 1063.38TRUE00
2027-01-1542.512.3PUT0 165.48TRUE00
2027-01-15450PUT0 063.74TRUE00
2027-01-1547.50PUT0 063.06TRUE00
2027-01-15500PUT0 062.24TRUE00
2027-01-1552.50PUT0 065.03TRUE00
2027-01-15550PUT0 062.48TRUE00
2027-01-1557.50PUT0 066.19TRUE00
2027-01-15600PUT0 067.69TRUE00
2027-01-15650PUT0 061.9TRUE00

Latest BHVN Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST40$143.84
Jun 13, 2022 7:59 PM EST9$143.84
Jun 13, 2022 7:59 PM EST8$143.87
Jun 13, 2022 7:59 PM EST100$143.87
Jun 13, 2022 7:59 PM EST3$143.83

Biohaven Pharmaceutical Holding Company Ltd (BHVN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000021545719006904/0000215457-19-006904-index.htm
2019-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000021545719008296/0000215457-19-008296-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000083423720008248/0000834237-20-008248-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000083423720009073/0000834237-20-009073-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465918071968/0001104659-18-071968-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919015412/0001104659-19-015412-index.htm
2019-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919020231/0001104659-19-020231-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919027408/0001104659-19-027408-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919027610/0001104659-19-027610-index.htm
2019-08-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000110465919046550/0001104659-19-046550-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920003210/0001104659-20-003210-index.htm
2020-01-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920009364/0001104659-20-009364-index.htm
2020-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920027268/0001104659-20-027268-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920041258/0001104659-20-041258-index.htm
2020-04-16DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1689813/000110465920047706/0001104659-20-047706-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920047741/0001104659-20-047741-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000114420419008285/0001144204-19-008285-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919118061265/0001209191-18-061265-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010164/0001209191-19-010164-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010166/0001209191-19-010166-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010174/0001209191-19-010174-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010177/0001209191-19-010177-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010184/0001209191-19-010184-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010209/0001209191-19-010209-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010214/0001209191-19-010214-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023434/0001209191-19-023434-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023435/0001209191-19-023435-index.htm
2019-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023859/0001209191-19-023859-index.htm
2019-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023860/0001209191-19-023860-index.htm
2019-04-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032463/0001209191-19-032463-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032465/0001209191-19-032465-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032466/0001209191-19-032466-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032468/0001209191-19-032468-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032470/0001209191-19-032470-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032472/0001209191-19-032472-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039192/0001209191-19-039192-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039193/0001209191-19-039193-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039411/0001209191-19-039411-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039412/0001209191-19-039412-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039783/0001209191-19-039783-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039785/0001209191-19-039785-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000127417319000086/0001274173-19-000086-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000127417320000063/0001274173-20-000063-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000141057819001022/0001410578-19-001022-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000141057819001524/0001410578-19-001524-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218019006297/0001562180-19-006297-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000346/0001562180-20-000346-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-01-313Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000722/0001562180-20-000722-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000723/0001562180-20-000723-index.htm
2020-03-125Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020002440/0001562180-20-002440-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003254/0001562180-20-003254-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003255/0001562180-20-003255-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003256/0001562180-20-003256-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003257/0001562180-20-003257-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003258/0001562180-20-003258-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004469/0001562180-20-004469-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004470/0001562180-20-004470-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-123/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004473/0001562180-20-004473-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004603/0001562180-20-004603-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005986/0001562180-20-005986-index.htm
2020-09-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006075/0001562180-20-006075-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006368/0001562180-20-006368-index.htm
2020-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2020-10-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-02-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000156223020000002/0001562230-20-000002-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000156223020000003/0001562230-20-000003-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000161577419002508/0001615774-19-002508-index.htm
2018-12-10S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1689813/000162828018014980/0001628280-18-014980-index.htm
2018-12-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1689813/000162828018014982/0001628280-18-014982-index.htm
2018-12-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1689813/000162828018014985/0001628280-18-014985-index.htm
2018-12-12S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1689813/000162828018015071/0001628280-18-015071-index.htm
2018-12-14424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1689813/000162828018015109/0001628280-18-015109-index.htm
2019-06-17S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1689813/000162828019008046/0001628280-19-008046-index.htm
2019-06-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828019008061/0001628280-19-008061-index.htm
2019-06-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828019008196/0001628280-19-008196-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000162828019008232/0001628280-19-008232-index.htm
2020-01-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828020000632/0001628280-20-000632-index.htm
2020-01-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828020000742/0001628280-20-000742-index.htm
2020-01-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000162828020000788/0001628280-20-000788-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981318000042/0001689813-18-000042-index.htm
2018-12-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1689813/000168981318000047/0001689813-18-000047-index.htm
2018-12-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1689813/000168981318000049/0001689813-18-000049-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000010/0001689813-19-000010-index.htm
2019-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000014/0001689813-19-000014-index.htm
2019-04-11DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000020/0001689813-19-000020-index.htm
2019-04-11DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000022/0001689813-19-000022-index.htm
2019-05-01DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000026/0001689813-19-000026-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000030/0001689813-19-000030-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000034/0001689813-19-000034-index.htm
2019-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000044/0001689813-19-000044-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000046/0001689813-19-000046-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000052/0001689813-19-000052-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000055/0001689813-19-000055-index.htm
2019-08-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000056/0001689813-19-000056-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000061/0001689813-19-000061-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-09-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000066/0001689813-19-000066-index.htm
2019-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2019-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2019-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000088/0001689813-19-000088-index.htm
2019-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000089/0001689813-19-000089-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000106/0001689813-19-000106-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000107/0001689813-19-000107-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000108/0001689813-19-000108-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000109/0001689813-19-000109-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000110/0001689813-19-000110-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000111/0001689813-19-000111-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000112/0001689813-19-000112-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000113/0001689813-19-000113-index.htm
2019-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000128/0001689813-19-000128-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000129/0001689813-19-000129-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000130/0001689813-19-000130-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000131/0001689813-19-000131-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000132/0001689813-19-000132-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000133/0001689813-19-000133-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000134/0001689813-19-000134-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000135/0001689813-19-000135-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000136/0001689813-19-000136-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000014/0001689813-20-000014-index.htm
2020-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1689813/000168981320000016/0001689813-20-000016-index.htm
2020-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000022/0001689813-20-000022-index.htm
2020-03-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000027/0001689813-20-000027-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000030/0001689813-20-000030-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000040/0001689813-20-000040-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981320000042/0001689813-20-000042-index.htm
2020-05-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000044/0001689813-20-000044-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000046/0001689813-20-000046-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000049/0001689813-20-000049-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000053/0001689813-20-000053-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981320000057/0001689813-20-000057-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000063/0001689813-20-000063-index.htm
2018-12-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1689813/999999999518003115/9999999995-18-003115-index.htm

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biohaven Pharmaceutical Holding Company Ltd (BHVN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1379%
Institutional Ownership: 11755%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-10-15Elyse StockChief Medical OfficerSell800.0045.0136,008.000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2019-10-18Elyse StockChief Medical OfficerSell17,700.0045.07797,749.620.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2019-02-04ERIC AGUIARDirectorSell17,609.0042.54749,086.860.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-09-11ERIC AGUIARDirectorSell10,000.0045.00450,000.000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-11-20ERIC AGUIARDirectorSell6,729.0052.20351,234.290.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-11-22ERIC AGUIARDirectorSell1,250.0055.2469,050.000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-12-09ERIC AGUIARDirectorSell4,072.0055.11224,410.770.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-16ERIC AGUIARDirectorSell3,537.0055.13194,984.550.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2019-01-10John TiltonChief Commercial OfficerSell10,500.0037.67395,535.000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-03-12John TiltonChief Commercial OfficerSell10,000.0050.11501,100.000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-02-21JULIA P GREGORYDirectorSell12,000.0043.56522,720.000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-11-22JULIA P GREGORYDirectorSell12,000.0054.75656,956.800.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-20Kimberly GentileSVP, Clinical OperationsSell3,935.0053.03208,665.180.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-11-21Kimberly GentileSVP, Clinical OperationsSell21,065.0053.041,117,205.450.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2020-01-09ERIC AGUIARDirectorSell30,000.0056.391,691,700.000.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2019-02-04ERIC AGUIARDirectorBuy10,000.0025.51255,100.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-09-11ERIC AGUIARDirectorBuy10,000.0025.51255,100.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-03-12John TiltonChief Commercial OfficerBuy10,000.009.2992,900.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-06-26JOHN W CHILDSDirectorBuy10,000.0040.37403,700.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039192/0001209191-19-039192-index.htm
2019-03-26Declan DooganDirectorSell5,824.0053.72312,865.281,014,827.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-03-22Declan DooganDirectorSell5,351.0053.66287,134.661,020,651.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-03-01Declan DooganDirectorSell50,000.0047.192,359,500.001,026,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-01-10John TiltonChief Commercial OfficerBuy10,500.009.2997,545.0010,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-03-22JOHN W CHILDSDirectorBuy107,500.009.29998,675.00107,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119023859/0001209191-19-023859-index.htm
2019-03-01Declan DooganDirectorSell595.0045.4127,018.951,076,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-02-27Declan DooganDirectorSell23,384.0045.711,068,882.641,076,597.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-12-18Vlad CoricChief Executive OfficerBuy10,950.0010,950.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000128/0001689813-19-000128-index.htm
2019-02-25Declan DooganDirectorSell13,943.0045.49634,267.071,099,981.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-19Declan DooganDirectorSell1,400.0045.5163,714.001,113,924.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-15Declan DooganDirectorSell678.0045.4230,794.761,115,324.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-13Declan DooganDirectorSell6,158.0044.24272,429.921,116,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2019-02-12Declan DooganDirectorSell33,842.0044.321,499,877.441,122,160.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2018-12-03Declan DooganDirectorSell40,000.0041.951,678,000.001,156,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919118061265/0001209191-18-061265-index.htm
2019-02-21JULIA P GREGORYDirectorBuy12,000.0023.63283,560.0012,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-11-22JULIA P GREGORYDirectorBuy12,000.0023.63283,560.0012,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-22ERIC AGUIARDirectorBuy1,250.0037.5446,925.001,250.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-12-18John TiltonCCO-Rare & Neurologic DisorderBuy1,250.001,250.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000133/0001689813-19-000133-index.htm
2020-01-08ERIC AGUIARDirectorBuy1,250.0055.9169,887.501,250.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-01-22ERIC AGUIARDirectorSell150.0058.868,828.601,250.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtBuy125,000.000.6176,250.00125,341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-12Elyse StockChief Medical OfficerSell15,925.0064.891,033,347.7713,234.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-19Robert BermanSpecial Projects & Med OvrsghtBuy986.000.61601.461,327.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-11James EngelhartChief Financial OfficerSell4,847.0063.19306,286.2913,475.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-01-22ERIC AGUIARDirectorSell200.0058.0011,599.001,400.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-10James EngelhartChief Financial OfficerBuy11,453.009.29106,398.3715,975.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-01-22ERIC AGUIARDirectorSell671.0056.9938,243.181,600.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtSell59,914.0075.254,508,822.081,741.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseSell1,300.0077.70101,005.061,755.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2019-02-04ERIC AGUIARDirectorBuy7,609.0020.79158,191.1117,609.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-10-18Elyse StockChief Medical OfficerBuy17,700.0010.82191,514.0017,700.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2020-06-11James EngelhartChief Financial OfficerSell5,972.0062.07370,697.5718,322.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-12Elyse StockChief Medical OfficerSell11,390.0065.80749,497.311,844.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-06-26Vlad CoricChief Executive OfficerBuy5,000.0040.22201,100.0019,130.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039193/0001209191-19-039193-index.htm
2020-01-22ERIC AGUIARDirectorBuy771.0032.4224,995.822,021.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-11-21Kimberly GentileSVP, Clinical OperationsBuy21,065.000.6112,849.6521,065.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsSell5,261.0075.62397,843.6621,878.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-12Elyse StockChief Medical OfficerBuy20,716.0020.79430,685.6422,560.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-01-22ERIC AGUIARDirectorSell500.0055.9927,995.502,271.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-06-27Robert BermanChief Medical OfficerBuy2,500.0042.30105,750.00240,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039411/0001209191-19-039411-index.htm
2020-06-11James EngelhartChief Financial OfficerBuy19,772.009.29183,681.8824,294.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-04-07JOHN W CHILDSDirectorSell14,734.0033.26490,119.142,476,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-08-11JOHN W CHILDSDirectorBuy2,600.0060.32156,823.942,479,538.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-08-11JOHN W CHILDSDirectorBuy7,271.0061.28445,567.612,486,809.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-04-07JOHN W CHILDSDirectorSell93,268.0032.923,070,130.742,491,672.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2019-06-27James EngelhartChief Financial OfficerBuy2,500.0043.05107,625.002,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039412/0001209191-19-039412-index.htm
2020-08-11JOHN W CHILDSDirectorBuy15,129.0061.87936,093.262,501,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-09-11JOHN W CHILDSDirectorBuy6,678.0059.00393,983.972,508,616.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005986/0001562180-20-005986-index.htm
2020-09-21JOHN W CHILDSDirectorBuy3,322.0059.25196,828.502,511,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006075/0001562180-20-006075-index.htm
2020-10-23Gregory BaileyDirectorSell212.0079.9416,948.002,545,658.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-23Gregory BaileyDirectorSell10,191.0078.89803,918.052,545,870.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-22Gregory BaileyDirectorSell3,100.0079.88247,632.032,556,061.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-22Gregory BaileyDirectorSell21,466.0079.411,704,720.242,559,161.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-19Gregory BaileyDirectorSell4,554.0078.98359,655.342,580,627.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2019-03-25Gregory BaileyDirectorBuy107,500.009.29998,675.002,582,601.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119023860/0001209191-19-023860-index.htm
2020-04-07JOHN W CHILDSDirectorSell10,908.0031.55344,196.492,584,940.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-10-16Gregory BaileyDirectorSell3,748.0078.88295,638.122,585,181.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2019-08-20Gregory BaileyDirectorBuy5,000.0037.65188,250.002,587,601.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000061/0001689813-19-000061-index.htm
2020-10-12Gregory BaileyDirectorSell6,729.0078.87530,740.452,588,929.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006368/0001562180-20-006368-index.htm
2020-07-08Gregory BaileyDirectorSell5,991.0075.93454,888.242,595,658.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-04-07JOHN W CHILDSDirectorSell81,090.0030.542,476,585.912,595,848.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-07-08Gregory BaileyDirectorSell44,009.0075.123,305,876.862,601,649.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-06-24Gregory BaileyDirectorSell2,395.0070.24168,224.802,645,658.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-24Gregory BaileyDirectorSell1,600.0069.29110,864.962,648,053.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-23Gregory BaileyDirectorSell835.0075.1862,779.312,649,653.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-23Gregory BaileyDirectorSell63,257.0074.604,719,256.862,650,488.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-04-06JOHN W CHILDSDirectorSell5,341.0031.76169,626.962,676,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-04-06JOHN W CHILDSDirectorSell144,659.0031.234,517,309.992,682,279.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-06-23Gregory BaileyDirectorSell24,084.0073.721,775,368.922,713,745.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsBuy23,500.009.29218,315.0027,139.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-23Gregory BaileyDirectorSell13,467.0072.70979,026.662,737,829.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-22Gregory BaileyDirectorSell49,132.0073.643,618,011.702,751,296.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-17Kimberly GentileSVP, Clinical OperationsBuy24,000.005.60134,400.0027,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-01-22ERIC AGUIARDirectorSell500.0054.9727,485.852,771.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-05Gregory BaileyDirectorBuy212,500.000.61129,625.002,800,101.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-22Gregory BaileyDirectorSell20,659.0072.911,506,202.242,800,428.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-22Gregory BaileyDirectorSell10,540.0072.01758,961.162,821,087.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell428.0075.2232,193.392,831,627.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell22,584.0073.781,666,267.852,832,055.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell12,157.0072.93886,618.522,854,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell21,798.0071.981,568,935.032,866,796.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell58,238.0070.914,129,854.592,888,594.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-12Elyse StockChief Medical OfficerSell5,300.0064.05339,448.0429,159.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-19Gregory BaileyDirectorSell26,814.0070.101,879,792.792,946,832.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-05Gregory BaileyDirectorBuy150,000.005.60840,000.002,950,101.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-10James EngelhartChief Financial OfficerSell28,821.0066.661,921,135.8129,654.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-19Gregory BaileyDirectorSell22,012.0069.011,519,094.352,973,646.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-05Gregory BaileyDirectorBuy37,700.009.29350,233.002,987,801.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2019-12-18WILLIAM A JR JONESCCO-Migraine & Common DiseaseBuy3,000.003,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000132/0001689813-19-000132-index.htm
2020-01-09ERIC AGUIARDirectorBuy30,000.009.29278,700.0030,000.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-06-05Gregory BaileyDirectorBuy20,000.0010.82216,400.003,007,801.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-05Gregory BaileyDirectorBuy18,000.0028.76517,680.003,025,801.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-01-09Kimberly GentileSVP, Clinical OperationsBuy1,000.0037.5437,540.003,049.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseSell4,010.0077.01308,799.273,055.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-07-08Robert BermanSpecial Projects & Med OvrsghtSell55,626.0075.254,185,745.253,119.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-06-10John TiltonChief Commercial OfficerSell21,364.0066.701,425,036.4831,406.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseBuy30,000.0050.721,521,600.0031,755.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-06-10John TiltonChief Commercial OfficerSell5,331.0068.57365,528.013,237.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-01-22ERIC AGUIARDirectorBuy1,250.0037.5446,925.003,271.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-10James EngelhartChief Financial OfficerBuy17,500.000.6110,675.0033,475.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-12-18Elyse StockChief Medical OfficerBuy3,375.003,375.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000134/0001689813-19-000134-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell300.0055.9716,791.00341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtSell1,400.0076.05106,467.48341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-19Robert BermanSpecial Projects & Med OvrsghtSell986.0075.0774,015.96341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-23Robert BermanSpecial Projects & Med OvrsghtSell4,296.0075.05322,431.12341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2020-07-08Robert BermanSpecial Projects & Med OvrsghtSell2,778.0075.29209,144.51341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-06-12Elyse StockChief Medical OfficerSell4,351.0063.02274,208.7234,459.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-12-16ERIC AGUIARDirectorBuy3,537.0020.7973,534.233,537.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2020-01-09Kimberly GentileSVP, Clinical OperationsBuy590.0020.7912,266.103,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-06-08Kimberly GentileSVP, Clinical OperationsSell600.0070.0542,027.483,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2020-06-17Kimberly GentileSVP, Clinical OperationsSell24,000.0070.201,684,869.603,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsSell2,458.0077.42190,300.083,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtBuy36,314.000.6122,151.5436,655.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2019-02-27Declan DooganDirectorSell1,900.0045.8687,134.00373,913.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-12-18Kimberly GentileSVP, Clinical OperationsBuy3,750.003,750.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000131/0001689813-19-000131-index.htm
2019-02-27Declan DooganDirectorSell18,270.0045.25826,717.50375,813.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2020-06-12Elyse StockChief Medical OfficerBuy16,250.0032.42526,825.0038,810.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-11-20Kimberly GentileSVP, Clinical OperationsBuy3,935.000.612,400.353,935.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-02-27Declan DooganDirectorSell6,875.0044.17303,668.75394,083.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-02-26Declan DooganDirectorSell100.0044.814,481.00400,958.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-26Declan DooganDirectorSell20,796.0044.31921,470.76401,058.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-17Kimberly GentileSVP, Clinical OperationsBuy400.005.602,240.004,039.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004603/0001562180-20-004603-index.htm
2019-12-09ERIC AGUIARDirectorBuy4,072.0020.7984,656.884,072.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell53,762.0053.432,872,449.904,129.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2019-02-25Declan DooganDirectorSell100.0045.744,574.00421,854.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-25Declan DooganDirectorSell20,334.0045.25920,113.50421,954.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-08Kimberly GentileSVP, Clinical OperationsBuy600.005.603,360.004,239.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2019-03-14Vlad CoricChief Executive OfficerSell15,783.0050.03789,623.49440,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-02-22Declan DooganDirectorSell16,050.0044.97721,768.50442,288.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-10James EngelhartChief Financial OfficerSell300.0068.0720,420.014,522.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-11James EngelhartChief Financial OfficerSell2,452.0064.85159,015.394,522.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-03-13Vlad CoricChief Executive OfficerSell8,262.0050.02413,265.24455,783.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-02-22Declan DooganDirectorSell5,575.0044.11245,913.25458,338.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-23Robert BermanSpecial Projects & Med OvrsghtBuy4,296.000.612,620.564,637.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2019-03-12Vlad CoricChief Executive OfficerSell25,955.0050.151,301,643.25464,045.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-14Vlad CoricChief Executive OfficerSell16,110.0050.02805,822.20475,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2020-06-10James EngelhartChief Financial OfficerSell24,832.0067.531,676,989.394,822.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-03-13Vlad CoricChief Executive OfficerSell7,883.0050.02394,307.66491,110.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-12Vlad CoricChief Executive OfficerSell26,007.0050.151,304,251.05498,993.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2020-06-10John TiltonChief Commercial OfficerBuy52,000.009.29483,080.0052,770.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell67,450.0052.953,571,349.3557,891.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-10James EngelhartChief Financial OfficerBuy25,000.005.60140,000.0058,475.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-07-08Robert BermanSpecial Projects & Med OvrsghtBuy58,404.000.6135,626.4458,745.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsSell15,781.0076.421,205,938.266,097.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtBuy25,000.005.60140,000.0061,655.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2019-12-18James EngelhartChief Financial OfficerBuy3,700.006,200.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000129/0001689813-19-000129-index.htm
2019-12-18Robert BermanSpecial Projects & Med OvrsghtBuy625.00625.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000136/0001689813-19-000136-index.htm
2020-06-16Declan DooganDirectorSell300.0069.4220,825.01626,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-16Declan DooganDirectorSell25,208.0068.731,732,457.61626,302.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell3,488.0054.89191,462.25641.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-16Declan DooganDirectorSell31,920.0067.902,167,514.83651,510.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2019-11-20ERIC AGUIARDirectorBuy6,729.0032.42218,154.186,729.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2020-06-16Declan DooganDirectorSell2,572.0066.94172,161.71683,430.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-15Declan DooganDirectorSell15,797.0068.101,075,800.98686,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-11James EngelhartChief Financial OfficerSell6,501.0064.31418,057.866,974.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-12-18Charles ConwayChief Scientific OfficerBuy3,000.007,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000135/0001689813-19-000135-index.htm
2020-06-15Declan DooganDirectorSell18,703.0067.511,262,557.24701,799.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseSell24,690.0076.021,876,872.087,065.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-06-15Declan DooganDirectorSell34,336.0066.052,267,872.20720,502.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-15Declan DooganDirectorSell11,164.0065.62732,560.47754,838.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-12Declan DooganDirectorSell25,914.0065.781,704,749.90766,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-10John TiltonChief Commercial OfficerSell2,467.0069.40171,201.91770.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-12Declan DooganDirectorSell28,086.0064.791,819,683.51791,916.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2019-10-15Elyse StockChief Medical OfficerBuy800.0010.828,656.00800.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2020-06-12Declan DooganDirectorSell18,400.0063.901,175,767.36820,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-12Declan DooganDirectorSell7,600.0062.93478,252.04838,402.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11Declan DooganDirectorSell25,039.0064.571,616,873.39846,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-10John TiltonChief Commercial OfficerSell22,838.0067.531,542,234.158,568.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-11Declan DooganDirectorSell18,474.0063.791,178,530.36871,041.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11Declan DooganDirectorSell20,043.0062.781,258,207.34889,515.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11Declan DooganDirectorSell16,444.0061.971,018,988.64909,558.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2019-04-16Declan DooganDirectorSell50,000.0061.923,096,000.00926,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm
2020-01-08Elyse StockChief Medical OfficerBuy937.0055.9152,387.67937.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000346/0001562180-20-000346-index.htm
2019-04-12Declan DooganDirectorSell38,825.0053.922,093,444.00976,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm